If you're looking for no-cost customized, personalized, one-on-one expert advice on all sorts of issues that people with MS encounter, you're going to want to pay attention to my conversation with Kay Julian, Executive Vice-President of Services at the National MS Society.
We're also talking about the demographic imbalance in MS clinical trials, and why that matters. (And you can find the Accelerated Cure Project's MS Minority Research Engagement Report here).
We're discussing the initial results of a clinical trial of a stem cell therapy that may reverse physical disability in progressive MS. It may turn out that a drug designed to improve walking for people with MS may have some additional benefits. And we're also talking about research from Penn State that may explain one reason why 50% of the people living with MS are going to be diagnosed with depression.